<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">32619303</PMID><DateCompleted><Year>2021</Year><Month>12</Month><Day>03</Day></DateCompleted><DateRevised><Year>2021</Year><Month>12</Month><Day>14</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1098-1136</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>12</Issue><PubDate><Year>2020</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Glia</Title><ISOAbbreviation>Glia</ISOAbbreviation></Journal><ArticleTitle>FABP7 upregulation induces a neurotoxic phenotype in astrocytes.</ArticleTitle><Pagination><StartPage>2693</StartPage><EndPage>2704</EndPage><MedlinePgn>2693-2704</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1002/glia.23879</ELocationID><Abstract><AbstractText>Fatty acid binding proteins (FABPs) are key regulators of lipid metabolism, energy homeostasis, and inflammation. They participate in fatty acid metabolism by regulating their uptake, transport, and availability of ligands to nuclear receptors. In the adult brain, FABP7 is especially abundant in astrocytes that are rich in cytoplasmic granules originated from damaged mitochondria. Mitochondrial dysfunction and oxidative stress have been implicated in the neurodegenerative process observed in amyotrophic lateral sclerosis (ALS), either as a primary cause or as a secondary component of the pathogenic process. Here we investigated the expression of FABP7 in animal models of human superoxide dismutase 1 (hSOD1)-linked ALS. In the spinal cord of symptomatic mutant hSOD1-expressing mice, FABP7 is upregulated in gray matter astrocytes. Using a coculture model, we examined the effect of increased FABP7 expression in astrocyte-motor neuron interaction. Our data show that FABP7 overexpression directly promotes an NF-&#x3ba;B-driven pro-inflammatory response in nontransgenic astrocytes that ultimately is detrimental for motor neuron survival. Addition of trophic factors, capable of supporting motor neuron survival in pure cultures, did not prevent motor neuron loss in cocultures with FABP7 overexpressing astrocytes. In addition, astrocyte cultures obtained from symptomatic hSOD1-expressing mice display upregulated FABP7 expression. Silencing endogenous FABP7 in these cultures decreases the expression of inflammatory markers and their toxicity toward cocultured motor neurons. Our results identify a key role of FABP7 in the regulation of the inflammatory response in astrocytes and identify FABP7 as a potential therapeutic target to prevent astrocyte-mediated motor neuron toxicity in ALS.</AbstractText><CopyrightInformation>&#xa9; 2020 Wiley Periodicals LLC.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Killoy</LastName><ForeName>Kelby M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Biomedical Sciences Training Program, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Harlan</LastName><ForeName>Benjamin A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Biomedical Sciences Training Program, Medical University of South Carolina, Charleston, South Carolina, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pehar</LastName><ForeName>Mariana</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Geriatrics and Gerontology, Department of Medicine, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vargas</LastName><ForeName>Marcelo R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0003-1039-4210</Identifier><AffiliationInfo><Affiliation>Department of Neurology, University of Wisconsin-Madison, Madison, Wisconsin, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS089640</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R21 NS102599</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AG062715</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>07</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Glia</MedlineTA><NlmUniqueID>8806785</NlmUniqueID><ISSNLinking>0894-1491</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C086936">Fabp7 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071438">Fatty Acid-Binding Protein 7</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="Y">Astrocytes</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071438" MajorTopicYN="N">Fatty Acid-Binding Protein 7</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NF-&#x3ba;B</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">astrocytes</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">motor neurons</Keyword></KeywordList><CoiStatement><b>Conflict of interest:</b> The authors declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>4</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>7</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32619303</ArticleId><ArticleId IdType="mid">NIHMS1637121</ArticleId><ArticleId IdType="pmc">PMC7573932</ArticleId><ArticleId IdType="doi">10.1002/glia.23879</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Armstrong EH, Goswami D, Griffin PR, Noy N, &amp; Ortlund EA (2014). Structural basis for ligand regulation of the fatty acid-binding protein 5, peroxisome proliferator-activated receptor beta/delta (FABP5-PPARbeta/delta) signaling pathway. J Biol Chem, 289(21), 14941&#x2013;14954. doi:10.1074/jbc.M113.514646</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.514646</ArticleId><ArticleId IdType="pmc">PMC4031543</ArticleId><ArticleId IdType="pubmed">24692551</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold ES, Ling SC, Huelga SC, Lagier-Tourenne C, Polymenidou M, Ditsworth D, &#x2026; Cleveland DW (2013). ALS-linked TDP-43 mutations produce aberrant RNA splicing and adult-onset motor neuron disease without aggregation or loss of nuclear TDP-43. Proc Natl Acad Sci U S A, 110(8), E736&#x2013;745. doi:10.1073/pnas.1222809110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1222809110</ArticleId><ArticleId IdType="pmc">PMC3581922</ArticleId><ArticleId IdType="pubmed">23382207</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey AP, Koster G, Guillermier C, Hirst EM, MacRae JI, Lechene CP, &#x2026; Gould AP (2015). Antioxidant Role for Lipid Droplets in a Stem Cell Niche of Drosophila. Cell, 163(2), 340&#x2013;353. doi:10.1016/j.cell.2015.09.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.09.020</ArticleId><ArticleId IdType="pmc">PMC4601084</ArticleId><ArticleId IdType="pubmed">26451484</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbeito LH, Pehar M, Cassina P, Vargas MR, Peluffo H, Viera L, &#x2026; Beckman JS (2004). A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis. Brain Res Brain Res Rev, 47(1-3), 263&#x2013;274. doi:10.1016/j.brainresrev.2004.05.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainresrev.2004.05.003</ArticleId><ArticleId IdType="pubmed">15572176</ArticleId></ArticleIdList></Reference><Reference><Citation>Bensimon G, Lacomblez L, &amp; Meininger V (1994). A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med, 330(9), 585&#x2013;591. doi:10.1056/NEJM199403033300901</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199403033300901</ArticleId><ArticleId IdType="pubmed">8302340</ArticleId></ArticleIdList></Reference><Reference><Citation>Brawer JR, Reichard G, Small L, &amp; Schipper HM (1994). The origin and composition of peroxidase-positive granules in cysteamine-treated astrocytes in culture. Brain Res, 633(1-2), 9&#x2013;20. doi:10.1016/0006-8993(94)91516-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-8993(94)91516-4</ArticleId><ArticleId IdType="pubmed">7511038</ArticleId></ArticleIdList></Reference><Reference><Citation>Brawer JR, Stein R, Small L, Cisse S, &amp; Schipper HM (1994). Composition of Gomori-positive inclusions in astrocytes of the hypothalamic arcuate nucleus. Anat Rec, 240(3), 407&#x2013;415. doi:10.1002/ar.1092400313</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ar.1092400313</ArticleId><ArticleId IdType="pubmed">7825737</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown RH, &amp; Al-Chalabi A (2017). Amyotrophic Lateral Sclerosis. N Engl J Med, 377(2), 162&#x2013;172. doi:10.1056/NEJMra1603471</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMra1603471</ArticleId><ArticleId IdType="pubmed">28700839</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai W, Yang T, Liu H, Han L, Zhang K, Hu X, &#x2026; Chen J (2017). Peroxisome proliferator-activated receptor gamma (PPARgamma): A master gatekeeper in CNS injury and repair. Prog Neurobiol. doi:10.1016/j.pneurobio.2017.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2017.10.002</ArticleId><ArticleId IdType="pmc">PMC6037317</ArticleId><ArticleId IdType="pubmed">29032144</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H, Qian K, Chen W, Hu B, Blackbourn L. W. t., Du Z, &#x2026; Zhang SC (2015). Human-derived neural progenitors functionally replace astrocytes in adult mice. J Clin Invest, 125(3), 1033&#x2013;1042. doi:10.1172/JCI69097</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI69097</ArticleId><ArticleId IdType="pmc">PMC4362241</ArticleId><ArticleId IdType="pubmed">25642771</ArticleId></ArticleIdList></Reference><Reference><Citation>Cozzolino M, Ferri A, Valle C, &amp; Carri MT (2013). Mitochondria and ALS: implications from novel genes and pathways. Mol Cell Neurosci, 55, 44&#x2013;49. doi:10.1016/j.mcn.2012.06.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2012.06.001</ArticleId><ArticleId IdType="pubmed">22705710</ArticleId></ArticleIdList></Reference><Reference><Citation>Daynes RA, &amp; Jones DC (2002). Emerging roles of PPARs in inflammation and immunity. Nat Rev Immunol, 2(10), 748&#x2013;759. doi:10.1038/nri912</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri912</ArticleId><ArticleId IdType="pubmed">12360213</ArticleId></ArticleIdList></Reference><Reference><Citation>de Boer AS, Koszka K, Kiskinis E, Suzuki N, Davis-Dusenbery BN, &amp; Eggan K (2014). Genetic validation of a therapeutic target in a mouse model of ALS. Sci Transl Med, 6(248), 248ra104. doi:10.1126/scitranslmed.3009351</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3009351</ArticleId><ArticleId IdType="pubmed">25100738</ArticleId></ArticleIdList></Reference><Reference><Citation>De Rosa A, Pellegatta S, Rossi M, Tunici P, Magnoni L, Speranza MC, &#x2026; Bakker A (2012). A radial glia gene marker, fatty acid binding protein 7 (FABP7), is involved in proliferation and invasion of glioblastoma cells. PLoS One, 7(12), e52113. doi:10.1371/journal.pone.0052113</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0052113</ArticleId><ArticleId IdType="pmc">PMC3528762</ArticleId><ArticleId IdType="pubmed">23284888</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Amarilla P, Olivera-Bravo S, Trias E, Cragnolini A, Martinez-Palma L, Cassina P, &#x2026; Barbeito L (2011). Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc Natl Acad Sci U S A, 108(44), 18126&#x2013;18131. doi:10.1073/pnas.1110689108</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1110689108</ArticleId><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Ditsworth D, Maldonado M, McAlonis-Downes M, Sun S, Seelman A, Drenner K, &#x2026; Da Cruz S (2017). Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis. Acta Neuropathol, 133(6), 907&#x2013;922. doi:10.1007/s00401-017-1698-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1698-6</ArticleId><ArticleId IdType="pmc">PMC5427168</ArticleId><ArticleId IdType="pubmed">28357566</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellinghaus P, Wolfrum C, Assmann G, Spener F, &amp; Seedorf U (1999). Phytanic acid activates the peroxisome proliferator-activated receptor alpha (PPARalpha) in sterol carrier protein 2-/ sterol carrier protein x-deficient mice. J Biol Chem, 274(5), 2766&#x2013;2772. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9915808</Citation><ArticleIdList><ArticleId IdType="pubmed">9915808</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsherbiny ME, Emara M, &amp; Godbout R (2013). Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma. Prog Lipid Res, 52(4), 562&#x2013;570. doi:10.1016/j.plipres.2013.08.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.plipres.2013.08.004</ArticleId><ArticleId IdType="pmc">PMC4461378</ArticleId><ArticleId IdType="pubmed">23981365</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuhashi M, Fucho R, Gorgun CZ, Tuncman G, Cao H, &amp; Hotamisligil GS (2008). Adipocyte/macrophage fatty acid-binding proteins contribute to metabolic deterioration through actions in both macrophages and adipocytes in mice. J Clin Invest, 118(7), 2640&#x2013;2650. doi:10.1172/JCI34750</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI34750</ArticleId><ArticleId IdType="pmc">PMC2423863</ArticleId><ArticleId IdType="pubmed">18551191</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuhashi M, &amp; Hotamisligil GS (2008). Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov, 7(6), 489&#x2013;503. doi:10.1038/nrd2589</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrd2589</ArticleId><ArticleId IdType="pmc">PMC2821027</ArticleId><ArticleId IdType="pubmed">18511927</ArticleId></ArticleIdList></Reference><Reference><Citation>Furuhashi M, Tuncman G, Gorgun CZ, Makowski L, Atsumi G, Vaillancourt E, &#x2026; Hotamisligil GS (2007). Treatment of diabetes and atherosclerosis by inhibiting fatty-acid-binding protein aP2. Nature, 447(7147), 959&#x2013;965. doi:10.1038/nature05844</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05844</ArticleId><ArticleId IdType="pmc">PMC4076119</ArticleId><ArticleId IdType="pubmed">17554340</ArticleId></ArticleIdList></Reference><Reference><Citation>Garin-Shkolnik T, Rudich A, Hotamisligil GS, &amp; Rubinstein M (2014). FABP4 attenuates PPARgamma and adipogenesis and is inversely correlated with PPARgamma in adipose tissues. Diabetes, 63(3), 900&#x2013;911. doi:10.2337/db13-0436</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/db13-0436</ArticleId><ArticleId IdType="pubmed">24319114</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillilan RE, Ayers SD, &amp; Noy N (2007). Structural basis for activation of fatty acid-binding protein 4. J Mol Biol, 372(5), 1246&#x2013;1260. doi:10.1016/j.jmb.2007.07.040</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jmb.2007.07.040</ArticleId><ArticleId IdType="pmc">PMC2032018</ArticleId><ArticleId IdType="pubmed">17761196</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, Alexander DD, &#x2026; et al. (1994). Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 264(5166), 1772&#x2013;1775. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/8209258</Citation><ArticleIdList><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips AM, Hester ME, Miranda CJ, Meyer K, Braun L, Frakes A, &#x2026; Kaspar BK (2011). Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat Biotechnol, 29(9), 824&#x2013;828. doi:10.1038/nbt.1957</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlan BA, Killoy KM, Pehar M, Liu L, Auwerx J, &amp; Vargas MR (2020). Evaluation of the NAD(+) biosynthetic pathway in ALS patients and effect of modulating NAD(+) levels in hSOD1-linked ALS mouse models. Exp Neurol, 327, 113219. doi:10.1016/j.expneurol.2020.113219</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2020.113219</ArticleId><ArticleId IdType="pmc">PMC7089832</ArticleId><ArticleId IdType="pubmed">32014438</ArticleId></ArticleIdList></Reference><Reference><Citation>Harlan BA, Pehar M, Killoy KM, &amp; Vargas MR (2019). Enhanced SIRT6 activity abrogates the neurotoxic phenotype of astrocytes expressing ALS-linked mutant SOD1. FASEB J, 33(6), 7084&#x2013;7091. doi:10.1096/fj.201802752R</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201802752R</ArticleId><ArticleId IdType="pmc">PMC6529338</ArticleId><ArticleId IdType="pubmed">30841754</ArticleId></ArticleIdList></Reference><Reference><Citation>Helledie T, Antonius M, Sorensen RV, Hertzel AV, Bernlohr DA, Kolvraa S, &#x2026; Mandrup S (2000). Lipid-binding proteins modulate ligand-dependent transactivation by peroxisome proliferator-activated receptors and localize to the nucleus as well as the cytoplasm. J Lipid Res, 41(11), 1740&#x2013;1751. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11060343</Citation><ArticleIdList><ArticleId IdType="pubmed">11060343</ArticleId></ArticleIdList></Reference><Reference><Citation>Hostetler HA, McIntosh AL, Atshaves BP, Storey SM, Payne HR, Kier AB, &amp; Schroeder F (2009). L-FABP directly interacts with PPARalpha in cultured primary hepatocytes. J Lipid Res, 50(8), 1663&#x2013;1675. doi:10.1194/jlr.M900058-JLR200</Citation><ArticleIdList><ArticleId IdType="doi">10.1194/jlr.M900058-JLR200</ArticleId><ArticleId IdType="pmc">PMC2724054</ArticleId><ArticleId IdType="pubmed">19289416</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotamisligil GS (2017). Inflammation, metaflammation and immunometabolic disorders. Nature, 542(7640), 177&#x2013;185. doi:10.1038/nature21363</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21363</ArticleId><ArticleId IdType="pubmed">28179656</ArticleId></ArticleIdList></Reference><Reference><Citation>Hotamisligil GS, &amp; Erbay E (2008). Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol, 8(12), 923&#x2013;934. doi:10.1038/nri2449</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2449</ArticleId><ArticleId IdType="pmc">PMC2814543</ArticleId><ArticleId IdType="pubmed">19029988</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Starodub O, McIntosh A, Atshaves BP, Woldegiorgis G, Kier AB, &amp; Schroeder F (2004). Liver fatty acid-binding protein colocalizes with peroxisome proliferator activated receptor alpha and enhances ligand distribution to nuclei of living cells. Biochemistry, 43(9), 2484&#x2013;2500. doi:10.1021/bi0352318</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi0352318</ArticleId><ArticleId IdType="pubmed">14992586</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H, Starodub O, McIntosh A, Kier AB, &amp; Schroeder F (2002). Liver fatty acid-binding protein targets fatty acids to the nucleus. Real time confocal and multiphoton fluorescence imaging in living cells. J Biol Chem, 277(32), 29139&#x2013;29151. doi:10.1074/jbc.M202923200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M202923200</ArticleId><ArticleId IdType="pubmed">12023965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannou MS, Jackson J, Sheu SH, Chang CL, Weigel AV, Liu H, &#x2026; Liu Z (2019). Neuron-Astrocyte Metabolic Coupling Protects against Activity-Induced Fatty Acid Toxicity. Cell, 177(6), 1522&#x2013;1535 e1514. doi:10.1016/j.cell.2019.04.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2019.04.001</ArticleId><ArticleId IdType="pubmed">31130380</ArticleId></ArticleIdList></Reference><Reference><Citation>Ju Lee H, Bartsch D, Xiao C, Guerrero S, Ahuja G, Schindler C, &#x2026; Vilchez D (2017). A post-transcriptional program coordinated by CSDE1 prevents intrinsic neural differentiation of human embryonic stem cells. Nat Commun, 8(1), 1456. doi:10.1038/s41467-017-01744-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01744-5</ArticleId><ArticleId IdType="pmc">PMC5682285</ArticleId><ArticleId IdType="pubmed">29129916</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannan-Thulasiraman P, Seachrist DD, Mahabeleshwar GH, Jain MK, &amp; Noy N (2010). Fatty acid-binding protein 5 and PPARbeta/delta are critical mediators of epidermal growth factor receptor-induced carcinoma cell growth. J Biol Chem, 285(25), 19106&#x2013;19115. doi:10.1074/jbc.M109.099770</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M109.099770</ArticleId><ArticleId IdType="pmc">PMC2885189</ArticleId><ArticleId IdType="pubmed">20424164</ArticleId></ArticleIdList></Reference><Reference><Citation>Kia A, McAvoy K, Krishnamurthy K, Trotti D, &amp; Pasinelli P (2018). Astrocytes expressing ALS-linked mutant FUS induce motor neuron death through release of tumor necrosis factor-alpha. Glia, 66(5), 1016&#x2013;1033. doi:10.1002/glia.23298</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.23298</ArticleId><ArticleId IdType="pmc">PMC5873384</ArticleId><ArticleId IdType="pubmed">29380416</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MJ, Vargas MR, Harlan BA, Killoy KM, Ball LE, Comte-Walters S, &#x2026; Pehar M (2018). Nitration and Glycation Turn Mature NGF into a Toxic Factor for Motor Neurons: A Role for p75(NTR) and RAGE Signaling in ALS. Antioxid Redox Signal, 28(18), 1587&#x2013;1602. doi:10.1089/ars.2016.6966</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ars.2016.6966</ArticleId><ArticleId IdType="pmc">PMC5962334</ArticleId><ArticleId IdType="pubmed">28537420</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtz A, Zimmer A, Schnutgen F, Bruning G, Spener F, &amp; Muller T (1994). The expression pattern of a novel gene encoding brain-fatty acid binding protein correlates with neuronal and glial cell development. Development, 120(9), 2637&#x2013;2649. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/7956838</Citation><ArticleIdList><ArticleId IdType="pubmed">7956838</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi L, Wang Z, Doud MK, Hazen SL, &amp; Noy N (2015). Saturated fatty acids regulate retinoic acid signalling and suppress tumorigenesis by targeting fatty acid-binding protein 5. Nat Commun, 6, 8794. doi:10.1038/ncomms9794</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms9794</ArticleId><ArticleId IdType="pmc">PMC4662070</ArticleId><ArticleId IdType="pubmed">26592976</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M, Pascual G, &amp; Glass CK (2000). Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Mol Cell Biol, 20(13), 4699&#x2013;4707. doi:10.1128/mcb.20.13.4699-4707.2000</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.20.13.4699-4707.2000</ArticleId><ArticleId IdType="pmc">PMC85890</ArticleId><ArticleId IdType="pubmed">10848596</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Y, Diehn M, Watson N, Bollen AW, Aldape KD, Nicholas MK, &#x2026; Israel MA (2005). Gene expression profiling reveals molecularly and clinically distinct subtypes of glioblastoma multiforme. Proc Natl Acad Sci U S A, 102(16), 5814&#x2013;5819. doi:10.1073/pnas.0402870102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0402870102</ArticleId><ArticleId IdType="pmc">PMC556127</ArticleId><ArticleId IdType="pubmed">15827123</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, MacKenzie KR, Putluri N, Maletic-Savatic M, &amp; Bellen HJ (2017). The Glia-Neuron Lactate Shuttle and Elevated ROS Promote Lipid Synthesis in Neurons and Lipid Droplet Accumulation in Glia via APOE/D. Cell Metab, 26(5), 719&#x2013;737 e716. doi:10.1016/j.cmet.2017.08.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2017.08.024</ArticleId><ArticleId IdType="pmc">PMC5677551</ArticleId><ArticleId IdType="pubmed">28965825</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu L, Zhang K, Sandoval H, Yamamoto S, Jaiswal M, Sanz E, &#x2026; Bellen HJ (2015). Glial lipid droplets and ROS induced by mitochondrial defects promote neurodegeneration. Cell, 160(1-2), 177&#x2013;190. doi:10.1016/j.cell.2014.12.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2014.12.019</ArticleId><ArticleId IdType="pmc">PMC4377295</ArticleId><ArticleId IdType="pubmed">25594180</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Longo LD, &amp; De Leon M (2000). In situ and immunocytochemical localization of E-FABP mRNA and protein during neuronal migration and differentiation in the rat brain. Brain Res, 852(1), 16&#x2013;27. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10661491</Citation><ArticleIdList><ArticleId IdType="pubmed">10661491</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Molina CA, Welcher AA, Longo LD, &amp; De Leon M (1997). Expression of DA11, a neuronal-injury-induced fatty acid binding protein, coincides with axon growth and neuronal differentiation during central nervous system development. J Neurosci Res, 48(6), 551&#x2013;562. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9210525</Citation><ArticleIdList><ArticleId IdType="pubmed">9210525</ArticleId></ArticleIdList></Reference><Reference><Citation>Makowski L, Boord JB, Maeda K, Babaev VR, Uysal KT, Morgan MA, &#x2026; Linton MF (2001). Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis. Nat Med, 7(6), 699&#x2013;705. doi:10.1038/89076</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/89076</ArticleId><ArticleId IdType="pmc">PMC4027052</ArticleId><ArticleId IdType="pubmed">11385507</ArticleId></ArticleIdList></Reference><Reference><Citation>Makowski L, Brittingham KC, Reynolds JM, Suttles J, &amp; Hotamisligil GS (2005). The fatty acid-binding protein, aP2, coordinates macrophage cholesterol trafficking and inflammatory activity. Macrophage expression of aP2 impacts peroxisome proliferator-activated receptor gamma and IkappaB kinase activities. J Biol Chem, 280(13), 12888&#x2013;12895. doi:10.1074/jbc.M413788200</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M413788200</ArticleId><ArticleId IdType="pmc">PMC3493120</ArticleId><ArticleId IdType="pubmed">15684432</ArticleId></ArticleIdList></Reference><Reference><Citation>Miquel E, Cassina A, Martinez-Palma L, Souza JM, Bolatto C, Rodriguez-Bottero S, &#x2026; Cassina P (2014). Neuroprotective effects of the mitochondria-targeted antioxidant MitoQ in a model of inherited amyotrophic lateral sclerosis. Free Radic Biol Med, 70, 204&#x2013;213. doi:10.1016/j.freeradbiomed.2014.02.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2014.02.019</ArticleId><ArticleId IdType="pubmed">24582549</ArticleId></ArticleIdList></Reference><Reference><Citation>Mita R, Beaulieu MJ, Field C, &amp; Godbout R (2010). Brain fatty acid-binding protein and omega-3/omega-6 fatty acids: mechanistic insight into malignant glioma cell migration. J Biol Chem, 285(47), 37005&#x2013;37015. doi:10.1074/jbc.M110.170076</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M110.170076</ArticleId><ArticleId IdType="pmc">PMC2978629</ArticleId><ArticleId IdType="pubmed">20834042</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M, Re DB, Nagata T, Chalazonitis A, Jessell TM, Wichterle H, &amp; Przedborski S (2007). Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat Neurosci, 10(5), 615&#x2013;622. doi:10.1038/nn1876</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Owada Y, Yoshimoto T, &amp; Kondo H (1996). Spatio-temporally differential expression of genes for three members of fatty acid binding proteins in developing and mature rat brains. J Chem Neuroanat, 12(2), 113&#x2013;122. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/9115666</Citation><ArticleIdList><ArticleId IdType="pubmed">9115666</ArticleId></ArticleIdList></Reference><Reference><Citation>Pascual G, Fong AL, Ogawa S, Gamliel A, Li AC, Perissi V, &#x2026; Glass CK (2005). A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature, 437(7059), 759&#x2013;763. doi:10.1038/nature03988</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature03988</ArticleId><ArticleId IdType="pmc">PMC1464798</ArticleId><ArticleId IdType="pubmed">16127449</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedersen WA, Fu W, Keller JN, Markesbery WR, Appel S, Smith RG, &#x2026; Mattson MP (1998). Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients. Ann Neurol, 44(5), 819&#x2013;824. doi:10.1002/ana.410440518</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440518</ArticleId><ArticleId IdType="pubmed">9818940</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M, Harlan BA, Killoy KM, &amp; Vargas MR (2017). Role and Therapeutic Potential of Astrocytes in Amyotrophic Lateral Sclerosis. Curr Pharm Des, 23(33), 5010&#x2013;5021. doi:10.2174/1381612823666170622095802</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612823666170622095802</ArticleId><ArticleId IdType="pmc">PMC5740017</ArticleId><ArticleId IdType="pubmed">28641533</ArticleId></ArticleIdList></Reference><Reference><Citation>Philips T, &amp; Robberecht W (2011). Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease. Lancet Neurol, 10(3), 253&#x2013;263. doi:10.1016/S1474-4422(11)70015-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70015-1</ArticleId><ArticleId IdType="pubmed">21349440</ArticleId></ArticleIdList></Reference><Reference><Citation>Pu L, Igbavboa U, Wood WG, Roths JB, Kier AB, Spener F, &amp; Schroeder F (1999). Expression of fatty acid binding proteins is altered in aged mouse brain. Mol Cell Biochem, 198(1-2), 69&#x2013;78. doi:10.1023/a:1006946027619</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1006946027619</ArticleId><ArticleId IdType="pubmed">10497880</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian K, Huang H, Peterson A, Hu B, Maragakis NJ, Ming GL, &#x2026; Zhang SC (2017). Sporadic ALS Astrocytes Induce Neuronal Degeneration In Vivo. Stem Cell Reports, 8(4), 843&#x2013;855. doi:10.1016/j.stemcr.2017.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.03.003</ArticleId><ArticleId IdType="pmc">PMC5390239</ArticleId><ArticleId IdType="pubmed">28366455</ArticleId></ArticleIdList></Reference><Reference><Citation>Reynolds JM, Liu Q, Brittingham KC, Liu Y, Gruenthal M, Gorgun CZ, &#x2026; Suttles J (2007). Deficiency of fatty acid-binding proteins in mice confers protection from development of experimental autoimmune encephalomyelitis. J Immunol, 179(1), 313&#x2013;321. doi:10.4049/jimmunol.179.1.313</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.1.313</ArticleId><ArticleId IdType="pubmed">17579051</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricote M, Li AC, Willson TM, Kelly CJ, &amp; Glass CK (1998). The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature, 391(6662), 79&#x2013;82. doi:10.1038/34178</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/34178</ArticleId><ArticleId IdType="pubmed">9422508</ArticleId></ArticleIdList></Reference><Reference><Citation>Sauer S (2015). Ligands for the Nuclear Peroxisome Proliferator-Activated Receptor Gamma. Trends Pharmacol Sci, 36(10), 688&#x2013;704. doi:10.1016/j.tips.2015.06.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2015.06.010</ArticleId><ArticleId IdType="pubmed">26435213</ArticleId></ArticleIdList></Reference><Reference><Citation>Sawada H (2017). Clinical efficacy of edaravone for the treatment of amyotrophic lateral sclerosis. Expert Opin Pharmacother, 18(7), 735&#x2013;738. doi:10.1080/14656566.2017.1319937</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14656566.2017.1319937</ArticleId><ArticleId IdType="pubmed">28406335</ArticleId></ArticleIdList></Reference><Reference><Citation>Schipper HM (1991). Gomori-positive astrocytes: biological properties and implications for neurologic and neuroendocrine disorders. Glia, 4(4), 365&#x2013;377. doi:10.1002/glia.440040404</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.440040404</ArticleId><ArticleId IdType="pubmed">1718859</ArticleId></ArticleIdList></Reference><Reference><Citation>Schipper HM, Song W, Tavitian A, &amp; Cressatti M (2019). The sinister face of heme oxygenase-1 in brain aging and disease. Prog Neurobiol, 172, 40&#x2013;70. doi:10.1016/j.pneurobio.2018.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2018.06.008</ArticleId><ArticleId IdType="pubmed">30009872</ArticleId></ArticleIdList></Reference><Reference><Citation>Schroeder F, Petrescu AD, Huang H, Atshaves BP, McIntosh AL, Martin GG, &#x2026; Kier AB (2008). Role of fatty acid binding proteins and long chain fatty acids in modulating nuclear receptors and gene transcription. Lipids, 43(1), 1&#x2013;17. doi:10.1007/s11745-007-3111-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11745-007-3111-z</ArticleId><ArticleId IdType="pubmed">17882463</ArticleId></ArticleIdList></Reference><Reference><Citation>Schug TT, Berry DC, Shaw NS, Travis SN, &amp; Noy N (2007). Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors. Cell, 129(4), 723&#x2013;733. doi:10.1016/j.cell.2007.02.050</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.02.050</ArticleId><ArticleId IdType="pmc">PMC1948722</ArticleId><ArticleId IdType="pubmed">17512406</ArticleId></ArticleIdList></Reference><Reference><Citation>Schupp M, &amp; Lazar MA (2010). Endogenous ligands for nuclear receptors: digging deeper. J Biol Chem, 285(52), 40409&#x2013;40415. doi:10.1074/jbc.R110.182451</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R110.182451</ArticleId><ArticleId IdType="pmc">PMC3003339</ArticleId><ArticleId IdType="pubmed">20956526</ArticleId></ArticleIdList></Reference><Reference><Citation>Sellner PA, Chu W, Glatz JF, &amp; Berman NE (1995). Developmental role of fatty acid-binding proteins in mouse brain. Brain Res Dev Brain Res, 89(1), 33&#x2013;46. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8575091</Citation><ArticleIdList><ArticleId IdType="pubmed">8575091</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi P, Gal J, Kwinter DM, Liu X, &amp; Zhu H (2010). Mitochondrial dysfunction in amyotrophic lateral sclerosis. Biochim Biophys Acta, 1802(1), 45&#x2013;51. doi:10.1016/j.bbadis.2009.08.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2009.08.012</ArticleId><ArticleId IdType="pmc">PMC2790551</ArticleId><ArticleId IdType="pubmed">19715760</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson EP, Henry YK, Henkel JS, Smith RG, &amp; Appel SH (2004). Increased lipid peroxidation in sera of ALS patients: a potential biomarker of disease burden. Neurology, 62(10), 1758&#x2013;1765. doi:10.1212/wnl.62.10.1758</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.62.10.1758</ArticleId><ArticleId IdType="pubmed">15159474</ArticleId></ArticleIdList></Reference><Reference><Citation>Smathers RL, &amp; Petersen DR (2011). The human fatty acid-binding protein family: evolutionary divergences and functions. Hum Genomics, 5(3), 170&#x2013;191. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21504868</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3500171</ArticleId><ArticleId IdType="pubmed">21504868</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith RG, Henry YK, Mattson MP, &amp; Appel SH (1998). Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis. Ann Neurol, 44(4), 696&#x2013;699. doi:10.1002/ana.410440419</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410440419</ArticleId><ArticleId IdType="pubmed">9778272</ArticleId></ArticleIdList></Reference><Reference><Citation>Song S, Miranda CJ, Braun L, Meyer K, Frakes AE, Ferraiuolo L, &#x2026; Kaspar BK (2016). Major histocompatibility complex class I molecules protect motor neurons from astrocyte-induced toxicity in amyotrophic lateral sclerosis. Nat Med, 22(4), 397&#x2013;403. doi:10.1038/nm.4052</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4052</ArticleId><ArticleId IdType="pmc">PMC4823173</ArticleId><ArticleId IdType="pubmed">26928464</ArticleId></ArticleIdList></Reference><Reference><Citation>Storch J, &amp; Thumser AE (2010). Tissue-specific functions in the fatty acid-binding protein family. J Biol Chem, 285(43), 32679&#x2013;32683. doi:10.1074/jbc.R110.135210</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.R110.135210</ArticleId><ArticleId IdType="pmc">PMC2963392</ArticleId><ArticleId IdType="pubmed">20716527</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun S, Sun Y, Ling SC, Ferraiuolo L, McAlonis-Downes M, Zou Y, &#x2026; Cleveland DW (2015). Translational profiling identifies a cascade of damage initiated in motor neurons and spreading to glia in mutant SOD1-mediated ALS. Proc Natl Acad Sci U S A, 112(50), E6993&#x2013;7002. doi:10.1073/pnas.1520639112</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1520639112</ArticleId><ArticleId IdType="pmc">PMC4687558</ArticleId><ArticleId IdType="pubmed">26621731</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, Phaneuf D, Dupre N, Petri S, Strong M, Kriz J, &amp; Julien JP (2011). Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways. J Exp Med, 208(12), 2429&#x2013;2447. doi:10.1084/jem.20111313</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111313</ArticleId><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan NS, Shaw NS, Vinckenbosch N, Liu P, Yasmin R, Desvergne B, &#x2026; Noy N (2002). Selective cooperation between fatty acid binding proteins and peroxisome proliferator-activated receptors in regulating transcription. Mol Cell Biol, 22(14), 5114&#x2013;5127. doi:10.1128/mcb.22.14.5114-5127.2002</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mcb.22.14.5114-5127.2002</ArticleId><ArticleId IdType="pmc">PMC139777</ArticleId><ArticleId IdType="pubmed">12077340</ArticleId></ArticleIdList></Reference><Reference><Citation>Thumser AE, Moore JB, &amp; Plant NJ (2014). Fatty acid binding proteins: tissue-specific functions in health and disease. Curr Opin Clin Nutr Metab Care, 17(2), 124&#x2013;129. doi:10.1097/MCO.0000000000000031</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0000000000000031</ArticleId><ArticleId IdType="pubmed">24500438</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas MR, Johnson DA, Sirkis DW, Messing A, &amp; Johnson JA (2008). Nrf2 activation in astrocytes protects against neurodegeneration in mouse models of familial amyotrophic lateral sclerosis. J Neurosci, 28(50), 13574&#x2013;13581. doi:10.1523/JNEUROSCI.4099-08.2008</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.4099-08.2008</ArticleId><ArticleId IdType="pmc">PMC2866507</ArticleId><ArticleId IdType="pubmed">19074031</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas MR, &amp; Johnson JA (2010). Astrogliosis in amyotrophic lateral sclerosis: role and therapeutic potential of astrocytes. Neurotherapeutics, 7(4), 471&#x2013;481. doi:10.1016/j.nurt.2010.05.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nurt.2010.05.012</ArticleId><ArticleId IdType="pmc">PMC2967019</ArticleId><ArticleId IdType="pubmed">20880509</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas MR, Pehar M, Cassina P, Beckman JS, &amp; Barbeito L (2006). Increased glutathione biosynthesis by Nrf2 activation in astrocytes prevents p75NTR-dependent motor neuron apoptosis. J Neurochem, 97(3), 687&#x2013;696. doi:10.1111/j.1471-4159.2006.03742.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2006.03742.x</ArticleId><ArticleId IdType="pubmed">16524372</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Xu G, Gonzales V, Coonfield M, Fromholt D, Copeland NG, &#x2026; Borchelt DR (2002). Fibrillar inclusions and motor neuron degeneration in transgenic mice expressing superoxide dismutase 1 with a disrupted copper-binding site. Neurobiol Dis, 10(2), 128&#x2013;138. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12127151</Citation><ArticleIdList><ArticleId IdType="pubmed">12127151</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Gutmann DH, &amp; Roos RP (2011). Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice. Hum Mol Genet, 20(2), 286&#x2013;293. doi:10.1093/hmg/ddq463</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq463</ArticleId><ArticleId IdType="pubmed">20962037</ArticleId></ArticleIdList></Reference><Reference><Citation>Welch JS, Ricote M, Akiyama TE, Gonzalez FJ, &amp; Glass CK (2003). PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci U S A, 100(11), 6712&#x2013;6717. doi:10.1073/pnas.1031789100</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1031789100</ArticleId><ArticleId IdType="pmc">PMC164512</ArticleId><ArticleId IdType="pubmed">12740443</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfrum C, Borchers T, Sacchettini JC, &amp; Spener F (2000). Binding of fatty acids and peroxisome proliferators to orthologous fatty acid binding proteins from human, murine, and bovine liver. Biochemistry, 39(6), 1469&#x2013;1474. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/10684629</Citation><ArticleIdList><ArticleId IdType="pubmed">10684629</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfrum C, Borrmann CM, Borchers T, &amp; Spener F (2001). Fatty acids and hypolipidemic drugs regulate peroxisome proliferator-activated receptors alpha - and gamma-mediated gene expression via liver fatty acid binding protein: a signaling path to the nucleus. Proc Natl Acad Sci U S A, 98(5), 2323&#x2013;2328. doi:10.1073/pnas.051619898</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.051619898</ArticleId><ArticleId IdType="pmc">PMC30137</ArticleId><ArticleId IdType="pubmed">11226238</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Chun SJ, Boillee S, Fujimori-Tonou N, Yamashita H, Gutmann DH, &#x2026; Cleveland DW (2008). Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci, 11(3), 251&#x2013;253. doi:10.1038/nn2047</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn2047</ArticleId><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Young JK, Baker JH, &amp; Muller T (1996). Immunoreactivity for brain-fatty acid binding protein in gomori-positive astrocytes. Glia, 16(3), 218&#x2013;226. doi:10.1002/(SICI)1098-1136(199603)16:3&amp;lt;218::AID-GLIA4&amp;gt;3.0.CO;2-Y</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/(SICI)1098-1136(199603)16:3&amp;lt;218::AID-GLIA4&amp;gt;3.0.CO;2-Y</ArticleId><ArticleId IdType="pubmed">8833192</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu S, Levi L, Casadesus G, Kunos G, &amp; Noy N (2014). Fatty acid-binding protein 5 (FABP5) regulates cognitive function both by decreasing anandamide levels and by activating the nuclear receptor peroxisome proliferator-activated receptor beta/delta (PPARbeta/delta) in the brain. J Biol Chem, 289(18), 12748&#x2013;12758. doi:10.1074/jbc.M114.559062</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.559062</ArticleId><ArticleId IdType="pmc">PMC4007463</ArticleId><ArticleId IdType="pubmed">24644281</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun SW, Leong C, Zhai D, Tan YL, Lim L, Bi X, &#x2026; Chang YT (2012). Neural stem cell specific fluorescent chemical probe binding to FABP7. Proc Natl Acad Sci U S A, 109(26), 10214&#x2013;10217. doi:10.1073/pnas.1200817109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1200817109</ArticleId><ArticleId IdType="pmc">PMC3387064</ArticleId><ArticleId IdType="pubmed">22689954</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>